GlassScriptPhysician profile
Randall Scott Joransen
NPI 1407858541
$6,535.55
in general payments reported to CMS, 2019-2025
43 companies · $1,209 in 2025
The $1,209 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $742 · 2020: $508 · 2021: $711 · 2022: $1,296 · 2023: $1,052 · 2024: $1,018 · 2025: $1,209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,278.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,330.30 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $541.34 | 2021-2025 | Verquvo |
| Philips North America LLC | $512.29 | 2020-2024 | (Bh4) Igt Devices Undivided, (Br5) Peripheral Ivus, (Am5) Lead Management |
| Janssen Pharmaceuticals, INC | $363.06 | 2019-2024 | Xarelto |
| Medtronic, INC. | $362.33 | 2021-2025 | Venaseal, Symplicity G3, Micra |
| Inari Medical, INC. | $309.02 | 2022 | |
| Abiomed | $295.37 | 2020-2025 | Impella |
| Pfizer INC. | $272.80 | 2019-2025 | |
| Angiodynamics, INC. | $213.12 | 2024 | Auryon Laser System 100-120 Vac |
| Shockwave Medical, INC | $208.21 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $200.01 | 2019-2023 | Farxiga |
| Surmodics, INC. | $178.11 | 2023-2025 | Pounce Venous Thrombectomy System, Pounce Thrombectomy System, Pounce Thrombectomy |
| Boston Scientific Corporation | $157.88 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $131.15 | 2019-2025 | Camzyos, Eliquis |
| Penumbra, INC. | $124.59 | 2025 | Indigo System, Penumbra System |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Joransen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.